The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 05, 2010

Filed:

Jan. 03, 2006
Applicants:

Josef Endl, Weilheim, DE;

Maria Elena Fuentes, Sunnyvale, CA (US);

Yvo Graus, Odijk, NL;

Adelbert Grossmann, Eglfing, DE;

Sebastian Neumann, Weilheim, DE;

Paul Parren, Odijk, NL;

Frank Rebers, Utrecht, NL;

Joerg Thomas Regula, Munich, DE;

Ralf Schumacher, Penzberg, DE;

Stefan Seeber, Penzberg, DE;

Jan Olaf Stracke, Penzberg, DE;

Kay-gunnar Stubenrauch, Penzberg, DE;

Jan Van DE Winkel, Zeist, NL;

Martine Van Vugt, Houten, NL;

Sandra Vereecken-verploegen, Nieuwegein, NL;

Inventors:

Josef Endl, Weilheim, DE;

Maria Elena Fuentes, Sunnyvale, CA (US);

Yvo Graus, Odijk, NL;

Adelbert Grossmann, Eglfing, DE;

Sebastian Neumann, Weilheim, DE;

Paul Parren, Odijk, NL;

Frank Rebers, Utrecht, NL;

Joerg Thomas Regula, Munich, DE;

Ralf Schumacher, Penzberg, DE;

Stefan Seeber, Penzberg, DE;

Jan Olaf Stracke, Penzberg, DE;

Kay-Gunnar Stubenrauch, Penzberg, DE;

Jan Van De Winkel, Zeist, NL;

Martine Van Vugt, Houten, NL;

Sandra Vereecken-Verploegen, Nieuwegein, NL;

Assignee:

Roche Palo Alto LLC, Palo Alto, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
Abstract

The instant specification discloses an antibody binding to IL-13Rα1, inhibiting IL-13 bioactivity and comprising a variable heavy and a variable light chain, characterized in that the variable heavy chain amino acid sequence CDR3 of this antibody is selected from the group consisting of the heavy chain CDR3 sequences of SEQ ID NO: 1, 3, 5, 7 or 9, and this antibody is useful in the treatment of asthma and allergic diseases.


Find Patent Forward Citations

Loading…